Structures by: Kou F.
Total: 15
C38H26CdN10,2(C6H2N3O7),2(C3H7NO)
C38H26CdN10,2(C6H2N3O7),2(C3H7NO)
Inorganica Chimica Acta (2012) 390, 12-21
a=14.255(3)Å b=26.996(5)Å c=20.182(6)Å
α=90.00° β=132.768(18)° γ=90.00°
C38H26N10Zn,2(C6H2N3O7),2(C3H7NO)
C38H26N10Zn,2(C6H2N3O7),2(C3H7NO)
Inorganica Chimica Acta (2012) 390, 12-21
a=14.221(3)Å b=26.462(5)Å c=20.396(6)Å
α=90.00° β=133.420(18)° γ=90.00°
C24H48Cl3N6O21Sm
C24H48Cl3N6O21Sm
Dalton transactions (Cambridge, England : 2003) (2016) 45, 46 18484-18493
a=19.5604(7)Å b=14.3327(5)Å c=14.8420(5)Å
α=90° β=100.143(2)° γ=90°
C24H48Cl3EuN6O21
C24H48Cl3EuN6O21
Dalton transactions (Cambridge, England : 2003) (2016) 45, 46 18484-18493
a=19.490(3)Å b=14.339(2)Å c=14.811(2)Å
α=90° β=100.191(2)° γ=90°
C24H48Cl3N6O21Tb
C24H48Cl3N6O21Tb
Dalton transactions (Cambridge, England : 2003) (2016) 45, 46 18484-18493
a=19.469(3)Å b=14.456(2)Å c=14.717(2)Å
α=90° β=100.331(2)° γ=90°
Bis[2,6-bis(1<i>H</i>-benzimidazol-2-yl)pyridine]nickel(II) dipicrate dimethylformamide disolvate
C38H26N10Ni2,2(C6H2N3O7),2(C3H7NO)
Acta Crystallographica Section E (2010) 66, 8 m967
a=14.2087(3)Å b=26.5215(5)Å c=14.6989(3)Å
α=90.00° β=93.7750(10)° γ=90.00°
(Dimethylformamide)(2-methylpropenoato)[tris(1-methyl-1<i>H</i>-benzimidazol- 2-ylmethyl)amine]manganese(II) perchlorate dimethylformamide solvate
C34H39MnN8O3,ClO4,C3H7NO
Acta Crystallographica Section E (2010) 66, 10 m1270
a=12.139(5)Å b=12.354(5)Å c=15.146(6)Å
α=89.168(4)° β=71.098(4)° γ=76.936(5)°
Bis[1,3-bis(1-methyl-1<i>H</i>-benzimidazol-2-yl)-2-oxapropane]cadmium dipicrate acetonitrile sesquisolvate 0.25-hydrate
C36H36CdN8O22,2(C6H2N3O7),1.5(C2H3N),0.25(H2O)
Acta Crystallographica Section E (2011) 67, 5 m647
a=28.5192(5)Å b=18.1631(3)Å c=25.4194(5)Å
α=90.00° β=122.6970(10)° γ=90.00°
[1,1-Dibenzyl-2,2'-(2-oxapropane-1,3-diyl)di(1<i>H</i>-benzimidazole)- κ^3^<i>N</i>^3^,<i>O</i>,<i>N</i>^3'^]bis(2,4,6-trinitrophenolato- κ<i>O</i>^1^)manganese(II)
C42H30MnN10O15
Acta Crystallographica Section E (2012) 68, 7 m923
a=22.323(6)Å b=10.937(3)Å c=34.130(9)Å
α=90.00° β=90.00° γ=90.00°
1,3-Bis(1-methyl-1<i>H</i>-benzimidazol-2-yl)-2-oxapropane
C18H18N4O
Acta Crystallographica Section E (2011) 67, 6 o1439
a=6.634(6)Å b=16.217(15)Å c=14.457(13)Å
α=90.00° β=101.102(10)° γ=90.00°
Bis[1,3-bis(1-ethyl-1<i>H</i>-benzimidazol-2-yl)-2-oxapropane]cadmium(II) dipicrate dimethylformamide disolvate
C40H44Cd1N8O22,2(C6H2N3O7),2C3H7NO
Acta Crystallographica Section E (2011) 67, 6 m768
a=14.1182(3)Å b=14.3444(3)Å c=16.0971(4)Å
α=98.2870(10)° β=107.9690(10)° γ=95.5260(10)°
Bis(nitrato-κ<i>O</i>)(3-oxapentane-1,5-diamine- κ^3^<i>N</i>,<i>O</i>,<i>N</i>)zinc(II)
C4H12N4O7Zn
Acta Crystallographica Section E (2011) 67, 6 m764
a=8.031(19)Å b=8.034(19)Å c=9.55(2)Å
α=103.97(2)° β=101.90(2)° γ=115.879(18)°
Bis[<i>N</i>,<i>N</i>-bis(1-allyl-1<i>H</i>-benzimidazol-2- ylmethyl-κ<i>N</i>^3^)benzylamine-κ^N^]cadmium dipicrate
C58H58CdN10,2(C6H2N3O7)
Acta Crystallographica Section E (2011) 67, 6 m800-m801
a=13.903(4)Å b=14.146(4)Å c=19.330(5)Å
α=90.595(3)° β=110.890(3)° γ=106.325(3)°
1-Methyl-2-({[(1-methyl-1<i>H</i>-benzimidazol-2- yl)methyl](phenyl)amino}methyl)1<i>H</i>-benzimidazol-3-ium picrate
C30H26N8O7
Acta Crystallographica Section E (2011) 67, 7 o1816
a=9.4233(5)Å b=12.3523(7)Å c=12.5772(7)Å
α=92.0070(10)° β=98.4970(10)° γ=103.6850(10)°
Bis[1,3-bis(1-propyl-1<i>H</i>-benzimidazol-2-yl)-2-oxapropane]cadmium(II) dipicrate dimethylformamide monosolvate
C44H52CdN8O22,2(C6H2N3O7),C3H7NO
Acta Crystallographica Section E (2011) 67, 10 m1461
a=14.211(6)Å b=14.997(7)Å c=16.190(7)Å
α=94.207(4)° β=112.449(4)° γ=97.986(4)°